A phase I/II triral of S-1 plus L-OHP for colorectal cancer liver metastases after hepatic resection

ABSTRACT: Interventions: S-1, Oxaliplatin Primary outcome(s): 3-year disease free survival Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Liver Metastases

PROVIDER: 2621828 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR